| 000 | 01491 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514003134.0 | ||
| 264 | 0 | _c20010809 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVasselli, J R | |
| 245 | 0 | 0 |
_aLack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cJul 2001 |
||
| 300 |
_a68-72 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
| 650 | 0 | 4 |
_aLymph Nodes _xpathology |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNephrectomy _xmethods |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRetroperitoneal Space |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aYang, J C | |
| 700 | 1 | _aLinehan, W M | |
| 700 | 1 | _aWhite, D E | |
| 700 | 1 | _aRosenberg, S A | |
| 700 | 1 | _aWalther, M M | |
| 773 | 0 |
_tThe Journal of urology _gvol. 166 _gno. 1 _gp. 68-72 |
|
| 999 |
_c11364908 _d11364908 |
||